KESTRA MEDICAL TECHNOLOGIES ($KMTS) posted quarterly earnings results for Q4 2026 on Tuesday, July 14th. The company reported earnings of -$0.67 per share, missing estimates of -$0.61 by $0.06. The company also reported revenue of $28,640,000, beating estimates of $27,008,580 by $1,631,420.
You can see Quiver Quantitative's $KMTS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KESTRA MEDICAL TECHNOLOGIES Insider Trading Activity
KESTRA MEDICAL TECHNOLOGIES insiders have traded $KMTS stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $KMTS stock by insiders over the last 6 months:
- BRIAN DANIEL WEBSTER (See Remarks) has made 0 purchases and 9 sales selling 90,000 shares for an estimated $1,957,309.
- RAYMOND W COHEN purchased 10,000 shares for an estimated $199,800
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
KESTRA MEDICAL TECHNOLOGIES Hedge Fund Activity
We have seen 55 institutional investors add shares of KESTRA MEDICAL TECHNOLOGIES stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,599,235 shares (+36.6%) to their portfolio in Q1 2026, for an estimated $31,872,753
- BLACKROCK, INC. added 454,561 shares (+36.8%) to their portfolio in Q1 2026, for an estimated $9,059,400
- OMEGA FUND MANAGEMENT, LLC removed 351,442 shares (-25.6%) from their portfolio in Q1 2026, for an estimated $7,004,239
- FRANKLIN RESOURCES INC added 292,197 shares (+30.7%) to their portfolio in Q1 2026, for an estimated $5,823,486
- STATE STREET CORP added 234,965 shares (+53.9%) to their portfolio in Q1 2026, for an estimated $4,682,852
- JENNISON ASSOCIATES LLC removed 219,355 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $4,371,745
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC removed 202,727 shares (-57.9%) from their portfolio in Q1 2026, for an estimated $4,040,349
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
KESTRA MEDICAL TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $KMTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 03/25/2026
To track analyst ratings and price targets for KESTRA MEDICAL TECHNOLOGIES, check out Quiver Quantitative's $KMTS forecast page.
KESTRA MEDICAL TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $KMTS recently. We have seen 2 analysts offer price targets for $KMTS in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- David Roman from Goldman Sachs set a target price of $17.0 on 04/09/2026
- Marie Thibault from BTIG set a target price of $32.0 on 04/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
